Previous 10 | Next 10 |
MENLO PARK, Calif., Nov. 01, 2023 (GLOBE NEWSWIRE) -- Corcept Therapeutics Incorporated (NASDAQ: CORT), a commercial-stage company engaged in the discovery and development of medications to treat severe endocrine, oncology, metabolism, and neurology disorders by modulating the effects of the horm...
MENLO PARK, Calif., Oct. 26, 2023 (GLOBE NEWSWIRE) -- Corcept Therapeutics Incorporated (NASDAQ: CORT), a commercial-stage company engaged in the discovery and development of medications to treat severe endocrine, oncology, metabolism, and neurology disorders by modulating the effects of the horm...
MENLO PARK, Calif., Oct. 25, 2023 (GLOBE NEWSWIRE) -- Corcept Therapeutics Incorporated (NASDAQ: CORT) today announced it will report third quarter financial results and provide a corporate update on November 1, 2023. The company will also host a conference call that day at 5:00 p.m. Eastern Time...
2023-09-15 13:31:19 ET Summary This month, I added to 5 different closed-end funds, but it came from the result of selling off 2 for swaps as well. Swap opportunities come up as we can exploit the discount/premium mechanics in closed-end funds. Overall, I have continued to sti...
2023-09-05 03:43:41 ET Summary I increased my portfolio investment in July-August to focus on stocks and funds in the Utilities sector, which has been underperforming. For July-August, I closed positions in 12 stocks in the portfolio, with a mean gain of +20.8% not including divid...
2023-09-01 12:17:32 ET Summary The John Hancock Tax-Advantaged Dividend Income Fund focuses on high-yielding dividend-paying stocks, particularly in the utility sector. The fund's declining share price presents an opportunity for investors, as it currently yields 8.61% and has a s...
2023-08-30 14:36:47 ET More on John Hancock Tax-Advantaged Dividend Income Fund HTD: Serviceable Utilities-Focused Equity Fund HTD: Income And Growth Potential Dividend scorecard for John Hancock Tax-Advantaged Dividend Income Fund For further details see: ...
2023-08-22 01:23:37 ET Summary Perfection is defined as being complete and correct in every way, and can be pursued in various fields, including art and investing. For years now, I have been employing all my strength in investing in CEFs and ETFs, plus some “flirtations...
2023-08-20 11:28:58 ET Summary John Hancock Premium Dividend Fund is currently looking like an attractive fund to consider due to its valuation. PDT recently underwent a distribution cut, which was the catalyst to open up the latest discount for the fund. No one likes distribu...
MENLO PARK, Calif., Aug. 02, 2023 (GLOBE NEWSWIRE) -- Corcept Therapeutics Incorporated (NASDAQ: CORT), a commercial-stage company engaged in the discovery and development of medications to treat severe endocrine, oncology, metabolism and neurology disorders by modulating the effects of the hormo...
News, Short Squeeze, Breakout and More Instantly...
John Hancock Tax Advantaged Dividend Income Fund of Beneficial Interest Company Name:
HTD Stock Symbol:
NYSE Market:
2024-07-12 04:12:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
2024-07-02 05:38:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
Results from the CATALYST clinical trial were presented at the American Diabetes Association’s 84 th Scientific Sessions at a featured plenary session titled: “Prevalence of Hypercortisolism in Difficult-to-Control Type 2 Diabetes” With 1,055 patients enro...